Comparative Benchmarking
In the context of the broader market, KALA competes directly with industry leaders such as ACRS and AKBA. With a market capitalization of $353.60M, it holds a significant position in the sector. When comparing efficiency, KALA's gross margin of N/A stands against ACRS's -13.44% and AKBA's 82.06%. Such benchmarking helps identify whether KALA BIO Inc is trading at a premium or discount relative to its financial performance.
